17-Hydroxyprogesterone caproate improves hypertension and renal endothelin-1 in response to sFlt-1 induced hypertension in pregnant rats

Keyphrases

• 17-hydroxyprogesterone (17-OHP) 63%
• 17α-hydroxyprogesterone Caproate 100%
• Clinical Characteristics 9%
• During Pregnancy 9%
• Early Delivery 9%
• Effective Treatment 9%
• Endothelin-1 (ET-1) 100%
• Fetoplacental Unit 9%
• Gestational Day 18%
• Hypertension 100%
• Induced Hypertension 100%
• Intraperitoneal Injection 9%
• Mean Arterial Pressure 27%
• MRNA Level 18%
• New-onset Hypertension 9%
• Nitrate 18%
• Nitrite Level 18%
• Placenta Weight 9%
• Placental Weight 9%
• Preeclampsia 36%
• Pregnant Rats 100%
• Premature Birth 9%
• Pupal Weight 9%
• Recurrent Preterm Birth 9%
• Renal Cortex 18%
• Soluble Fms-like Tyrosine kinase-1 (sFlt-1) 100%
• Sprague-Dawley Rats 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Endothelin 1 100%
• Epileptic Absence 9%
• Hydroxyprogesterone Caproate 100%
• Intraperitoneal Injection 9%
• Nitrite 18%
• Preeclampsia 36%
• Premature Labor 9%
• Prematurity 9%
• Preproendothelin 1 9%
• Protein Tyrosine Kinase 100%
• Sprague Dawley Rat 9%

Biochemistry, Genetics and Molecular Biology

• 17-Hydroxyprogesterone 100%
• Endothelin 1 100%
• Mean Arterial Pressure 27%
• Messenger RNA 18%
• Placenta Weight 18%
• Pregnancy 9%
• Soluble Fms-Like Tyrosine Kinase-1 100%
• Sprague Dawley Rat 9%